Properties (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Shasun_Pharmaceuticals
gptkb:Onco_Therapies_Limited |
| gptkbp:CEO |
R._S._S._S._Raghunandan
|
| gptkbp:certifications |
gptkb:FDA
EMA TGA WHO |
| gptkbp:employees |
Over 3,000
|
| gptkbp:facilities |
gptkb:Bangalore
gptkb:Australia gptkb:Singapore gptkb:USA |
| gptkbp:focus |
Manufacturing
Research and development Distribution |
| gptkbp:founded |
1990
|
| gptkbp:founder |
R._S._S._S._Raghunandan
|
| gptkbp:headCoach |
3,000+
|
| gptkbp:headquarters |
gptkb:Bangalore,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Strides Pharma Inc.
|
| gptkbp:investmentFocus |
R&D investment
Manufacturing facilities Market expansion |
| gptkbp:location |
gptkb:Australia
gptkb:India gptkb:USA Africa Europe |
| gptkbp:market |
Global market
|
| gptkbp:partnerships |
Research institutions
Local distributors Various international pharmaceutical companies Healthcare_providers |
| gptkbp:productLine |
Biologics
Topicals Injectables Oral solids |
| gptkbp:products |
Over-the-counter medications
Generic_pharmaceuticals |
| gptkbp:revenue |
$500 million (2021)
|
| gptkbp:stockExchange |
gptkb:BSE
NSE |
| gptkbp:subsidiary |
Strides Pharma Global Pte Ltd
Strides_Pharma_Canada_Inc. |
| gptkbp:sustainability |
Community engagement
Environmental initiatives Ethical sourcing Employee welfare programs Waste management practices |
| gptkbp:type |
Public
|
| gptkbp:website |
www.strides.com
|